JPMorgan analyst Jessica Fye raised the price target on Crinetics (NASDAQ: CRNX) to $47.00 (from $35.00) while maintaining a Overweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE